TM9SF4

Transmembrane 9 superfamily member 4 · Q92544 · TM9SF4 on Sugi Atlas →

0 patent compounds predicted against TM9SF4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TM9SF4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Pembrolizumab (MK-3475) in MM Patients With Residual Disease PHASE2COMPLETED
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study) PHASE1/PHASE2WITHDRAWN
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy PHASE2COMPLETED
Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation PHASE2UNKNOWN
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma PHASE2UNKNOWN
68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis EARLY_PHASE1UNKNOWN
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis EARLY_PHASE1RECRUITING
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Evaluation of Risk of hEpatocellular Carcinoma nanRECRUITING
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors nanUNKNOWN
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System nanUNKNOWN
The Development of Human Immunologic Assays Specific to Folate Receptor Antigen nanUNKNOWN
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases nanRECRUITING
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Lifestyle Intervention in Fatty Liver (NAFLD) nanUNKNOWN
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application nanCOMPLETED
Differential Expression of CD200 in B-chronic Lymphoproliferative Disorders by Multicolour Flow Cytometry nanUNKNOWN
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
FAPI Molecular Imaging for Diagnosis of the CMS4 Unfavorable Colorectal Cancer Subtype nanRECRUITING
Study of Constitutional Platelet Disease nanUNKNOWN
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
Immunophenotypic Evaluation of CD305 and CD85d in B-Cell Lymphoid Neoplasms nanNOT_YET_RECRUITING
Immune Cell Response to Stimuli nanRECRUITING
Purinergic Signaling and the Postmenopausal Heart nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TM9SF4 binder may also engage these)

ProteinNameSimilarity
Q8BH24 1.000 Q8BH24 →
Q9LIC2 1.000 Q9LIC2 →
Q9C720 1.000 Q9C720 →
Q9ET30 1.000 Q9ET30 →
A5D7E2 1.000 A5D7E2 →
Q5RDY2 1.000 Q5RDY2 →
Q940G0 1.000 Q940G0 →
Q9C5N2 1.000 Q9C5N2 →
Q9FYQ8 1.000 Q9FYQ8 →
Q4KLL4 1.000 Q4KLL4 →
Q9Y819 0.999 Q9Y819 →
Q5R8Y6 0.999 Q5R8Y6 →
F4KIB2 0.998 F4KIB2 →
Q8RWW1 0.997 Q8RWW1 →
TM9SF2 Transmembrane 9 superfamily member 2 0.997 landscape →
F4JRE0 0.997 F4JRE0 →
P58021 0.996 P58021 →
TM9SF3 Transmembrane 9 superfamily member 3 0.995 landscape →
Q54ZW0 0.995 Q54ZW0 →
Q66HG5 0.995 Q66HG5 →
Q55FP0 0.995 Q55FP0 →
Q04562 0.993 Q04562 →
Q18695 0.992 Q18695 →
Q9DBU0 0.991 Q9DBU0 →
O15321 0.991 O15321 →
Q5R8F1 0.990 Q5R8F1 →
Q06537 0.990 Q06537 →
Q54XK2 0.990 Q54XK2 →
P93766 0.989 P93766 →
Q9FKY5 0.989 Q9FKY5 →